বেলজিয়াম - জার্মান - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

mylan - metformin hydrochlorid - filmtablette - 850 mg - metformin hydrochlorid 850 mg - metformin

বেলজিয়াম - জার্মান - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz - metformin hydrochlorid - filmtablette - 500 mg - metformin hydrochlorid 500 mg - metformin

বেলজিয়াম - জার্মান - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz - metformin hydrochlorid - filmtablette - 850 mg - metformin hydrochlorid 850 mg - metformin

সুইজারল্যান্ড - জার্মান - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - metformini hydrochloridum - filmtabletten - metformini hydrochloridum 500 mg, magnesii stearas, povidonum k 90, povidonum k 30, Überzug: hypromellosum, e 171, macrogolum 400, pro compresso obducto. - antidiabetikum - synthetika

সুইজারল্যান্ড - জার্মান - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - metformini hydrochloridum - filmtabletten - metformini hydrochloridum 850 mg, magnesii stearas, povidonum k 90, povidonum k 30, Überzug: hypromellosum, e 171, macrogolum 400, pro compresso obducto. - antidiabetikum - synthetika

সুইজারল্যান্ড - জার্মান - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - metformini hydrochloridum - filmtabletten - metformini hydrochloridum 1000 mg, magnesii stearas, povidonum k 90, povidonum k 30, Überzug: hypromellosum, e 171, macrogolum 400, pro compresso obducto. - antidiabetikum - synthetika

ইউরোপীয় ইউনিয়ন - জার্মান - EMA (European Medicines Agency)

astrazeneca ab - dapagliflozin-propandiol-monohydrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - drogen bei diabetes verwendet - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. zusätzlich zu anderen arzneimitteln für die behandlung von typ-2-diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 und 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.

ইউরোপীয় ইউনিয়ন - জার্মান - EMA (European Medicines Agency)

astrazeneca ab - dapagliflozin-propandiol-monohydrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - drogen bei diabetes verwendet - type 2 diabetes mellitusforxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. zusätzlich zu anderen arzneimitteln für die behandlung von typ-2-diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 und 5. heart failureforxiga is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseforxiga is indicated in adults for the treatment of chronic kidney disease.

সুইজারল্যান্ড - জার্মান - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - metformini hydrochloridum, sitagliptinum - filmtabletten - metformini hydrochloridum 500 mg, sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, cellulosum microcristallinum, povidonum k 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), e 171, macrogola, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 1.025 mg. - diabetes typ 2 - synthetika

সুইজারল্যান্ড - জার্মান - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - metformini hydrochloridum, sitagliptinum - filmtabletten - metformini hydrochloridum 850 mg, sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, cellulosum microcristallinum, povidonum k 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: lactosum monohydricum 13.7 mg, hypromellosum, e 171, triacetinum, e 172 (rubrum), pro compresso obducto corresp. natrium 1.74 mg. - diabetes typ 2 - synthetika